- Latest available (Revised)
- Original (As adopted by EU)
Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (Text with EEA relevance) (revoked)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
There are currently no known outstanding effects for the Regulation (EC) No 1901/2006 of the European Parliament and of the Council.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
TITLE I INTRODUCTORY PROVISIONS
TITLE II MARKETING AUTHORISATION REQUIREMENTS
CHAPTER 1 General authorisation requirements
Article 7.(1) An application for marketing authorisation under Article 6 of Directive...
Article 8.In the case of authorised medicinal products which are protected...
Article 9.Articles 7 and 8 shall not apply to products authorised...
Article 10.In consultation with the Member States, the Agency and other...
CHAPTER 3 Paediatric investigation plan
Section 1 Requests for agreement
Article 15.(1) Where the intention is to apply for a marketing...
Article 16.(1) In the case of the applications for marketing authorisation...
Article 17.(1) Following receipt of a proposed paediatric investigation plan which...
Article 18.As soon as the Paediatric Committee adopts an opinion, whether...
Article 19.If, having considered a paediatric investigation plan, the Paediatric Committee...
TITLE V REWARDS AND INCENTIVES
Article 36.(1) Where an application under Article 7 or 8 includes...
Article 37.Where an application for a marketing authorisation is submitted in...
Article 38.(1) Where a paediatric use marketing authorisation is granted in...
Article 39.(1) In addition to the rewards and incentives provided for...
Article 40.(1) Funds for research into medicinal products for the paediatric...
TITLE VI COMMUNICATION AND COORDINATION
Article 41.(1) The European database created by Article 11 of Directive 2001/20/EC...
Article 42.Member States shall collect available data on all existing uses...
Article 43.(1) On the basis of the information referred to in...
Article 44.(1) The Agency shall, with the scientific support of the...
Article 45.(1) By 26 January 2008, any paediatric studies already completed,...
Article 46.(1) Any other marketing authorisation holder-sponsored studies which involve the...
TITLE VII GENERAL AND FINAL PROVISIONS
Article 52.Regulation (EEC) No 1768/92 is hereby amended as follows: in Article 1,...
Article 53.In Article 11 of Directive 2001/20/EC, the following paragraph shall be...
Article 54.In Article 6 of Directive 2001/83/EC, the first subparagraph of paragraph...
Article 55.Regulation (EC) No 726/2004 is hereby amended as follows: Article 56(1) shall...
ATTACHMENTS
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: